Thrombosis in ovarian cancer: a case control study
Open Access
- 21 January 2014
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 110 (5) , 1118-1124
Abstract
Thrombotic events are common in cancer patients and have been associated with an adverse prognosis in large registry-based studies. A retrospective cohort of 417 patients with ovarian cancer treated at a tertiary cancer centre between 2006 and 2009 was studied to identify the incidence and risk factors for thrombotic events and the prognostic impact of thrombosis. Patient outcomes were evaluated against a matched control group without thrombosis. Ninety-nine thrombotic events occurred in 90 patients (21.6%) from 8 months before diagnosis to 56 months following diagnosis, peaking in the 4 months following diagnosis. Patients with thrombosis were older (mean 65 vs 61 years, P=0.007), had a worse performance status (PS ≥2: 29.9% vs 9.5%, P<0.0001) and had a more advanced FIGO stage (FIGO III/IV 75.6% vs 56.9%, P<0.0001) than patients without thrombosis. Shorter overall survival was seen in patients with pulmonary embolism and pelvic/lower limb deep vein thrombosis than without thrombosis (P=0.001). When the control group was matched for stage and PS, no survival difference was seen (P=0.91). Ovarian cancer patients with thrombotic events had a shorter survival. However, when matched for prognostic factors (PS and FIGO stage), thrombosis did not impact upon prognosis.Keywords
This publication has 18 references indexed in Scilit:
- When ‘never-events’ occur despite adherence to clinical guidelines: The case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypesGynecologic Oncology, 2010
- Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO)Thrombosis Research, 2009
- Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Undergoing Platinum/Paclitaxel–Containing First-Line Chemotherapy: An Exploratory Analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study GroupJournal of Clinical Oncology, 2008
- Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patientsCancer, 2007
- High incidence of silent venous thromboembolism before treatment in ovarian cancerBritish Journal of Cancer, 2007
- Venous thromboembolism in ovarian cancerGynecologic Oncology, 2007
- Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapyJournal of Thrombosis and Haemostasis, 2007
- Tissue factor expression as a possible determinant of thromboembolism in ovarian cancerBritish Journal of Cancer, 2007
- Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With CancerJournal of Clinical Oncology, 2006
- Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common CancersArchives of internal medicine (1960), 2006